· February 8, 2010 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil® for Hyperphosphatemia
· January 26, 2010 3SBio Inc. To Report 2009 Fourth Quarter And Full Year Results on February 11, 2010
· January 8, 2009 3SBio Inc. Applies For SFDA Registrational Trial For Feraheme™
· November 12, 2009 3SBio Inc. Announces Unaudited Third Quarter 2009 Results